Click Here to Register »

2017 Agenda

  • 8:00 am

  • Exhibit Hall Opens

    • Registration
      Hosted by:

    • Badge and Material Pick Up
    • Breakfast

  • DPharm Part I: Patients, Innovation and Disruption

  • 8:45 am

  • Patient Keynote Speaker

  • 9:20 am

  • Co-Chair's Opening Remarks


    Andreas Koester, MD, PhD

    VP, Innovation, R&D Operations, Janssen


    Craig Lipset, MBA

    Head of Clinical Innovation, Pfizer, Inc


    Bray Patrick-Lake, MFS

    Director of Stakeholder Engagement, Duke Clinical Research Institute

  • 9:30 am

  • R&D Executives on What They Want to Disrupt

    This is a quick fire session to learn what some of the most influential companies are prioritizing in innovation for the advancement of clinical trials. Audience members will be invited to share ambitious projects they want to stretch. Our goal at DPharm is to widely communicate an understanding of our different goals so that we can help each other.


    Michelle Shogren
    Portfolio and Operations Innovation Manager, Global Clinical Development, Bayer


    Jennifer Wulff

    Director, Clinical Innovation, Pfizer, Inc


    Ülo Palm, MD, PhD

    SVP, Drug Development Operations, Allergan

    Genentech rep TBA

  • 10:00 am

  • Bootstrapping Innovation: How Eli Lilly and Pfizer Make Innovation a Reality in Clinical Trials

    We are frequently requested to include a session at DPharm that walks attendees through the process of how pharma is accelerating the adoption of new ideas and technologies. In this session, Eli Lilly and Pfizer share and compare some of their approaches and processes to accelerate the adoption of new technologies and ideas, as well as discussing challenges and obstacles.


    Craig Lipset, MBA

    Head of Clinical Innovation, Pfizer, Inc


    Barry Crist

    Lead Investigator, Lilly Clinical Open Innovation Team, Eli Lilly & Company

  • 10:30 am

  • ADAPTABLE: Aspirin Study – A New System to Do Clinical Studies

    ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) is a three-year pragmatic clinical trial that will compare the effectiveness of two different daily doses of aspirin widely used to prevent heart attacks and strokes in individuals living with heart disease. In this trial, patients are being reached out to electronically via email and via a patient portal. What makes this especially interesting is that patients are actively engaged in the design, conduct, oversight, and dissemination.


    Adrian Hernandez, MD

    Co-Principal Investigator, ADAPTABLE, the Aspirin Study, PCORnet

  • 11:00 am

  • Morning Networking Session

    • Ask the Patients: An opportunity to meet with patients who have experienced a clinical trial
    • Meet the exhibitors
    • Technology demos
    • Virtual reality demos
    • AI demos
    • Coffee/tea, etc
    • Partnering tables
  • 11:45 am

  • Myth Buster #1

    Introduced by:


    Laura Galuchie

    TransCelerate Program Lead, Merck


    Stephanie Petrone

    Executive Director, Medical Operations, Novartis

    Myth: You can’t bring a trial to the patient.

    Myth Busted: TBA

  • 12:10 pm

  • Setting a New Gold Standard for Participants in Research

    More information to come!

  • 12:40 pm

  • General Session Activity

  • 1:00 pm

  • Lunch and Networking


  • DPharm Part II: New Ideas and Progress – you will be surprised who is leading some of the advances!

  • 2:00 pm

  • Patient Disrupters: The Ultimate Partner!

    Hear how these patients are driving the research. A look at the reality of our future in clinical research.

    Reducing the Burden of Type 1 Diabetes through a Model of Democratized R&D


    Dana Lewis

    Creator, Do-It-Yourself Pancreas System and Founder, OpenAPS

     

    Patient-Initiated Research & Crowdsourced Science Meet Academic Medicine: The Story of SCAD Research


    Sharonne Hayes, MD

    Principal Investigator, Mayo Clinic Spontaneous Coronary Artery Dissection (SCAD) Research Program, Mayo Clinic

     

    A Cancer Survivor on Making Real World Inclusion Criteria a Reality


    John-Peter Bradford, PhD

    CEO, Life-Saving Therapies Network

  • 3:00 pm

  • Turbo Tax for Clinical Trials: A Case Study

    In this session, Jae will give us a brief overview on how goBalto has advanced study start up and provide new data on benchmarking performance.

    Jae_Chung
    Jae Chung, MBA

    President & Founding Visionary, goBalto


    Lorena Gomez

    Director of Global Study Startup, Allergan

  • 3:15 pm
    - 4:30 pm

  • Choice of Two Tracks

    • Track One: Where are They Now?

      This track highlights companies who have shared their innovation at a previous DPharm conference, but have exciting advances to report on.

      Presenting Companies:

      3:20 pm

      AiCure
      Adam Hanina, MBA
      CEO

       

      3:30 pm

      Science 37
      Noah Craft, MD, PhD, DTMH
      Co-Founder and CEO


      3:40 pm

      TrialX Inc
      Sharib Khan, MD, MPH

      Co-founder and CEO


      3:50 pm

      Veeva Systems
      Henry Levy

      Chief Strategy Officer


      4:00 pm

      Target Health
      Jules Mitchel, PhD

      President


      4:10 pm

      Tom GottschalkRxSolutions
      Tom Gottschalk

      Executive Director, Business Development


      4:15 pm

      Medpoint Digital
      Bill Cooney, MBA

      President and CEO


      4:20 pm

      randol spaulding

      Spaulding Clinical Research (DPharm Idol winner 2012)
      Randy Spaulding
      CEO and Founder

    • Track Two: Innovative Sources and Solutions

      This track features companies who are new to presenting at DPharm and have interesting technologies and services to help with clinical trial management, matching, acceleration and recruitment.

      Presenting Companies:

      3:20 pm

      YPrime
      Shawn Blackburn

      CEO

       

      3:35 pm

      Elligo Health Research
      Deirdre BeVard

      Chief Operating Officer

       

      3:45 pm

      Ben LiuTrialspark
      Benjamine Liu

      CEO and Founder

       

      3:55 pm

      Ivor ClarkeSubjectWell
      Ivor Clarke

      CEO

       

      4:00 pm
      Biospective Inc

      Barry Bedell, MD, PhD
      COO and CSO

      4:05 pm
      ASD Healthcare
      Chris Flori

      VP Business Innovation

      Two more sessions available!

  • 4:30 pm

  • Afternoon Networking Session

    • Ask the Patients: An opportunity to meet with patients who have experienced a clinical trial
    • Meet the exhibitors
    • Technology demos
    • Virtual reality demos
    • AI demos
    • Refreshments
    • Boston’s oldest chocolates: Philips chocolate turtles
    • Partnering tables
    • Patient empathy teachers with therapy dogs
    • Art therapy booth
  • 5:00 pm

  • DPharm Idol 2017

    DPharm Idol is the concluding session of day one. In a live-show format, a select group of innovators present what they believe to be a disruptive service or technology that could be a changing force for clinical trials. Each company provides a quick-fire session followed by questions from the DPharm Idol judges. The exchange of Q&A is so helpful to see what you should either be asking or communicating for your own trials.

    Who will be the DPharm Idol 2017 winner? Florence Healthcare, our DPharm Idol 2016 winner, will tell us where they are a year later and kick off DPharm Idol 2017.

    DPharm Idol 2016 Winner Kick Off:


    Ryan Jones, MBA

    CEO, Florence Healthcare

     

    Presenting Companies as of 7/12:

    Outcome Health
    Don Butler

    SVP of Clinical Research Solutions

    Deep6 AI
    Wout Brusselaers

    CEO and Co-founder

    eClinical Solutions
    Sam Anwar

    VP, Engineering

    More companies TBA

     

    DPharm Idol Judges as of 7/12:


    Esther Dyson

    Chairman, Adventure Holdings


    Laura Galuchie

    TransCelerate Program Lead, Merck


    Andreas Koester, MD, PhD

    VP, Innovation, R&D Operations, Janssen


    Craig Lipset, MBA

    Head of Clinical Innovation, Pfizer, Inc

    Jacob LaPorte
    Jacob LaPorte, PhD

    Head of Digital Development, Novartis


    Ülo Palm, MD, PhD

    SVP, Drug Development Operations, Allergan

    Chandra Ramanathan
    Chandra Ramanathan, PhD, MBA

    Head, East Coast Innovation Center, Bayer, US


    Jane Rhodes, PhD

    Senior Director, New Initiatives, Biogen Idec

    Additional Judges to be Announced

  • 6:00 pm
    - 7:30 pm

  • DPharm Annual Reception

2017 Agenda

  • 8:00 am

  • Exhibit Hall Opens

    Breakfast and Networking


  • DPharm Part III: The Next Generation of Ideas

  • 8:30 am

  • Co-Chair's Address and DPharm Idol 2017 Winner Announced


    Andreas Koester, MD, PhD

    VP, Innovation, R&D Operations, Janssen


    Craig Lipset, MBA

    Head of Clinical Innovation, Pfizer, Inc


    Bray Patrick-Lake, MFS

    Director of Stakeholder Engagement, Duke Clinical Research Institute

  • 8:45 am

  • Blockchain for Drug Development: A Historic Opportunity!

    Pfizer is making advances in working with blockchain and has been one of the first companies to deliver prototype applications on the chain early this year. In this session, learn from an industry insider how blockchain can speed up the drug development process and change the business model of clinical development. Hear why it is imperative to embrace blockchain. More specifically:

    • The basics on how blockchain works and what the key advantages are
    • Key benefits to empowering patients with control over their data
    • The compliance implications of unalterable historic audit trails
    • How in-house proof of concept development fosters innovation and new technology adoption
    • The implications of rich and abundant patient data for the drug development process


    Sascha Mundstein, PhD, MBA

    Mobile and Digital COE, Technology Evangelist, Pfizer, Inc

  • 9:25 am
    - 9:50 am

  • Two Track Choices

    • Track One: Aligning Incentives to Share Clinical Data

      9:30 am

      Dr Isaac (Zak) Kohane reports on the outcome of The SPRINT Challenge, a practical example and “poster child” of data sharing in today’s environment.

      • How the challenge / contest was set up around the question, “Why are we not sharing data from clinical trials?”
      • What did the trialists say about why they would or would not share data?
      • What was the patients’ perspective?
      • Did having more people reviewing the data improve its quality and usefulness?
      • What did we learn about aligning incentives to share clinical data?
      • How can we create a proper framework for sharing data, which currently doesn’t exist?
      • How can we promote opportunities to democratize access to data for new analyses that can go beyond a trial’s primary outcome findings?


      Isaac (Zak) Kohane, MD, PhD

      Chair of the Department of Biomedical Informatics, Harvard Medical School

    • Track Two: Wireless Remote Monitoring – Next Frontier for Patients

      9:30 am

      MIT Professor, Dina Katabi, joins us for a chat about in-home non-intrusive patient monitoring and provides a demo of technology that uses ambient radio signals to monitor a patient’s gait, falls, breathing, heart rate and even sleep, all without putting any sensor on the patient’s body. Find out how they have used the technology to redefine clinical endpoints and pushed clinical trials to the home.


      Prof Dina Katabi
      MacArthur Fellow, Andrew & Erna Viterbi ProfessorMIT, and Director of MIT Center for Wireless Networks and Mobile Computing

  • 9:50 am

  • The DPharm Today Show with Craig Lipset, MBA, Head of Clinical Innovation, Pfizer, Inc

    In this annual interview style session, co-chair Craig Lipset welcomes guests to the DPharm stage, who are involved in innovative projects that can help clinical research.

    Topics and Guests:

    Focus on the Goal and Not the Role


    Esther Dyson

    Chairman, Adventure Holdings

    How the Banking World is Securely Giving Customers Access to their Data

    Speaker TBA

    The Alexa Challenge, Voice & Other Emerging Technologies for Clinical Trials


    Sara Holoubek, MBA

    CEO, Luminary Labs

  • 11:00 am

  • Morning Networking Session

    • Ask the Patients: An opportunity to meet with patients who have experienced a clinical trial
    • Meet the exhibitors
    • Technology demos
    • Virtual reality demos
    • AI demos
    • Coffee/tea, etc
    • Chocolates by Philips, Boston’s oldest chocolatier
    • Partnering tables
    • Patient empathy teachers with therapy dogs
    • Art therapy booth
  • 11:40 am

  • Engaging Patients by Giving Them What they Want…their Data!


    Andreas Koester, MD, PhD

    VP, Innovation, R&D Operations, Janssen

  • 12:00 pm

  • Building a Strategic Patients Community Beyond Clinical Trials

    If you want to give patients data back, you need a community. In this session, you will learn how this works.


    Thomas Klein

    Founder and CEO, Be the Partner

  • 12:20 pm

  • Co-Chair Interview

    More information to come!

  • 12:30 pm
    - 1:15 pm

  • Three Track Choices

    • Track One: Digital Therapeutics

      12:35 pm

      Digital Therapeutics, Gaming as a Therapy: Who Is Doing What and Where Are They Now?

      Insights on:

      • Digital therapeutics for enhanced clinical outcomes
      • How to use digital as part of the treatment
      • How to incorporate digital therapeutics in clinical trials
      • When does it make sense to use digital therapeutics?


      Eddie Martucci, PhD

      CEO, Akili Interactive Labs


      Jason Kahn, PhD

      Co-Founder and CSO
      Neuromotion Labs

    • Track Two: Customer Centric and the Digital Patient Journey

      12:35 pm- 12:55 pm

      Myth Buster #2 –
      Flip the Clinic

      Myth: Innovation always relies on technology.

      Myth Busted: No, it does not. It happened.

      Whitney Bowman-Zatzkin
      Whitney Bowman-Zatzkin, MPA, MSR

      Director, Flip the Clinic

    • Creating a Digital Journey for the Patient

      12:55 pm- 1:15 pm

      “Fit for Patient”


      Paulo Moreira

      VP, Global Clinical Operations, External Innovation, EMD Serono

    • Track Three: New Innovation from Old Science and Artificial Intelligence

      12:35 pm- 12:55 pm

      The Next Generation of Clinical Trials: Lessons from the Hurdles of the Microbiome


      Zain Kassam, MD, MPH

      CMO, OpenBiome

    • How Artificial Intelligence will Impact Healthcare of the Future and in Particular Clinical Trials

      12:55 pm- 1:15 pm

      What are the capabilities for clinical trials?


      Zen Chu, MBA

      Faculty Director, MIT Healthcare Ventures and Hacking Medicine

  • 1:15 pm

  • Lunch and Optional Lunch Session

    Clinical Research as a Care Option (CRAACO)


  • DPharm Part IV: The concluding portion of DPharm is composed of a series of brief, but impactful sessions devoted to progress in innovation from all stakeholders.

  • 2:15 pm

  • The Patient Ambassador Program at the NHS

  • 2:45 pm

  • Where Are They Now: Eli Lilly’s Hero’s Journey Project


    Kelly McKee

    Advisor, Clinical Innovation, Eli Lilly & Company

  • 3:00 pm

  • Investing in Digital Biomarkers

    • What do we need to know?
    • What is the reality of digital biomarkers in measuring disease?
    • What is the pathway?

    Led by:


    Joseph Kim, MBA

    Senior Advisor, Clinical Innovation, Eli Lilly & Company


    Sohini Chowdhury
    Deputy CEO, The Michael J. Fox Foundation 
  • 3:30 pm

  • Turning Opportunity into Reality: Real Data and Practical Guidance

    This panel discussion brings together key industry voices, who are collaborating on recommendations for the use of mobile technology in clinical trials. The insights come from the work of CTTI’s Mobile Clinical Trials Program. They share the latest findings and draft recommendations after the point of informed consent on the use of mobile technologies in regulated clinical trials. This will include the patient perspective, tips for dealing with large volumes of data, engaging with FDA during trial design, execution, and monitoring. Join us for an evidence-based and thought-provoking discussion of real data and practical guidance to actualize these opportunities.

    Moderator:


    Komathi Stem

    Founder, monARC Biotech

    Panelists:


    Ray Dorsey, MD, MBA

    David M. Levy Professor of Neurology and Director of the CHET, University of Rochester


    Cindy Geoghegan

    Principal, Patient and Partners LLC


    Gary Grabow, JD

    Assistant General Counsel, Genentech

  • 4:10 pm

  • TransCelerate Report on Progress and Next Steps to Drive Innovation in Clinical Research

    In this brief report, hear about the strategic priorities of TransCelerate in a discussion on selected ongoing and recently initiated projects.


    Andreas Koester, MD, PhD

    VP, Innovation, R&D Operations, Janssen


    Craig Lipset, MBA

    Head of Clinical Innovation, Pfizer, Inc


    Ülo Palm, MD, PhD

    SVP, Drug Development Operations, Allergan

  • 4:30 pm

  • Myth Buster #3

    Myth: Data Donation App.

    Myth Busted: It’s happening.


    Munther Baara

    Senior Director, Clinical Paradigm, Pfizer, Inc

  • 5:00 pm

  • DPharm 2017 Concludes

2017 Agenda


  • DPharm Pre-Conference Workshop

    Wednesday, September 6, 2017   |   7:00 pm – 9:00 pm

    Limited Seating Available. Attendance Optional.


    Trial Innovation Co-Design Workshop: Help Create Solutions to Assist Clinical Research Participants

    Overview

    In this optional pre-conference hands-on workshop, you get to be an innovator! Using co-design and human-centered approaches, you will work with a small team to brainstorm and design an innovation to assist participants in Clinical Trials. For the purpose of this co-design workshop, you might think a smart pill bottle could help patients remember to take their trial medication, or maybe a smart refrigerator could help trial staff manage their supply of study drug. In this interactive workshop, we will guide you through a collaborative design process that helps you create practical solutions using Ambient Intelligence, the Internet of Things, and Smart Devices.

    Led by:

    Barry Crist
    Lead Investigator, Lilly Clinical Open Innovation Team, Eli Lilly & Company

    Barry leads a group of designers and techies in Lilly’s Clinical Development Innovation Lab, where they do imagineering for patient-centric research. He is the Lead Investigator for the Lilly Clinical Open Innovation Team. Barry has spent his career leveraging information to transform the way people do work. He is a technologist, an architect, a seeker, a problem solver – and has a passion-fueled vision that drives a unique ability to make big ideas come to life. Prior to Lilly, Barry worked for many years at the U.S. Department of Energy’s Savannah River Site. This is a 300 square-mile facility with multiple nuclear reactors and chemical processing facilities. Barry was responsible for digitizing a half a million paper engineering drawings (blueprints, essentially) and make them smarter. Barry is a graduate of Purdue University where he studied computer technology. 


    Workshop Information

    • Open to registered DPharm attendees, with an additional fee of $395.00.
    • The workshop is limited to 50 people.

    Registration Instructions